
Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.
Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.
Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.